尼日利亚众议院发起了NHIS药品定价审查,以应对不断上升的医疗保健成本. Nigerian House of Representatives initiates NHIS medicine pricing review to tackle rising healthcare costs.

尼日利亚众议院已开始审查国家健康保险计划(NHIS)的医药价格,原因是经济挑战和保健费用上涨。 The Nigerian House of Representatives has initiated a review of the National Health Insurance Scheme's (NHIS) medicine pricing due to economic challenges and rising healthcare costs. 联合委员会将与卫生当局合作,重新评估2021年更新的过时价格清单,并在两周内提交调查结果。 A joint committee will collaborate with health authorities to reassess the outdated price list, last updated in 2021, and submit findings within two weeks. 这一行动旨在提高弱势人群在持续通货膨胀情况下获得药品的能力。 This action aims to improve medication affordability for vulnerable populations amid ongoing inflation.